| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0856 | Az-ghs-38 | Novel CNS penetrant potent inverse agonist of GHS-R1a (IC 50 (affinity) = 0.77 nM) |
|
| DCC0857 | Azide-a-dsbso Featured | Azide-A-DSBSO crosslinker is a mass spectrometry (MS)-cleavable, membrane-permeable, homobifunctional, azide-labeled, acid-cleavable cross-linked peptide. Azide-A-DSBSO crosslinker enables the study of protein-protein interactions via cross-linking mass spectrometry (XL-MS). |
|
| DCC0858 | Azido-tpp1 | Mitochondria-luciferin releasing agent, reacting with mitochondria-activatable luciferin (MAL-Probe), such as TPP-CL2, to release luciferin |
|
| DCC0859 | Azithromycin Monohydrate | Macrolide antibiotic, binding to the 50S subunit of the bacterial ribosome and thus inhibiting translation of mRNA |
|
| DCC0860 | Azocholine | Excellent photoswitchable agonist for neuronal α7 nAChRs |
|
| DCC0861 | Azogw1929 | Novel photoswitchable agonist for peroxisome proliferator-activated receptor γ (PPARγ) |
|
| DCC0862 | Azolig 9 | Novel photoswitchable ligand for the cannabinoid receptor 2 (CB2) |
|
| DCC0863 | Azorosi-4 | Novel photoswitchable agonist for peroxisome proliferator-activated receptor γ (PPARγ) |
|
| DCC0864 | Az-pfkfb3-26 | Potent and selective PFKFB3 inhibitor |
|
| DCC0865 | Azumamide E | Natural potent HDAC inhibitor |
|
| DCC0866 | Az-vem | Novel chimeric inhibitor of dimeric RAF, inhibiting B-Raf V600E mutan |
|
| DCC0867 | B07 Hydrochloride | Novel CCR5 antagonist-based HIV-1 entry inhibitor |
|
| DCC0868 | Ba-53038b | Novel HBV core protein allosteric modulator (CpAM), bing to the HAP pocket and modulating HBV capsid assembly in a distinct manner |
|
| DCC0869 | Baa485 | Novel activator of Pyrin inflammasome |
|
| DCC0870 | Bace1-in-cpd C | Novel potent nonbrain-penetrant BACE1 inhibitor |
|
| DCC0871 | Baclmk | Allosteric Inhibitor of the NS2B-NS3 Protease from Dengue Virus |
|
| DCC0872 | Bag-1 Inhibitor Thio-2 | Novel inhibitor of BAG-1-mediated protein interactions, targeting the RAF-MEK-ERK signaling pathway, transformed cells |
|
| DCC0873 | Bak2-66 | Selective Dopamine D3 Receptor Antagonist |
|
| DCC0874 | Bal101553 Dihydrochloride | Novel microtubule inhibitor as the prodrug of BAL27862, activating spindle assembly checkpoint, exerting antiproliferative effects and dose-dependent vascular disruption |
|
| DCC0875 | Balanol | Potent ATP-competitive inhibitor of Protein Kinase C (PKC) and Protein Kinase A (PKA) |
|
| DCC0876 | Balofloxacin Hydrate | Antibacterial; Antimicrobial; Inhibitor of DNA gyrase and intracellular accumulation of quinolones |
|
| DCC0877 | Bam Complex Inhibitor 14 | Novel BAM complex inhibitor, interferring with BamA-related processes and affect folding and insertion of OMPs |
|
| DCC0878 | Bam Complex Inhibitor 2 | Novel BAM complex inhibitor, interferring with BamA-related processes and affect folding and insertion of OMPs |
|
| DCC0879 | Banoxantrone Dihydrochloride | Hypoxia-activated prodrug of topoisomerase II inhibitor |
|
| DCC0880 | baq Diphosphate | Antimalarial; Novel Chloroquine analog against Chloroquine-Resistant Parasites |
|
| DCC0881 | Barbatolic Acid | Natural anti-breast cancer and anti-angiogenic agent |
|
| DCC0882 | Barbigerone | Inhibitor of tumor angiogenesis, growth and metastasis in melanoma |
|
| DCC0883 | Barixibat | Bile acid transporter inhibitor |
|
| DCC0884 | Bas00127538 | The first small molecule inhibitor of Lipid II |
|
| DCC0885 | Bashy-btz 5 | Novel fluorescent Bortezomib-GV1001 conjugate for monitoring the delivery of the proteasome inhibitor bortezomib (Btz) to HT-29 cancer cells, exhibiting an improved cytoplasmic availability |
|
